New diabetes clinical trial: Pinto Beans and Glycemic Control in Adults With Type 2 Diabetes | | |
New diabetes clinical trial: Diabetes, Exercise and Liver Fat (DELIVER) | | Published on: July 02, 2019 at 07:00PM Conditions: Type 2 Diabetes Mellitus; Non-Alcoholic Fatty Liver Disease; Obesity; Insulin Resistance; Liver Diseases; Fatty Liver; Diabetes Mellitus; Glucose Metabolism Disorders; Glucose Intolerance; Metabolic Disease Intervention: Behavioral: Exercise Sponsors: James King; University Hospitals, Leicester; Nottingham University Hospitals NHS Trust; University of Nottingham Recruiting https://clinicaltrials.gov/ct2/show/NCT04004273?term=diabetes&sfpd_d=14 July 02, 2019 at 02:41PM via ClinicalTrials.gov |
New diabetes clinical trial: Kidney Biopsy Indications in Type 2 Diabetes Patients | | |
New diabetes clinical trial: C-peptide Concentrations in Type 2 Diabetes Treated With Insulin; is it Time to Revise the Treatment of Type 2 Diabetes | | |
New diabetes clinical trial: Remission of Type 2 Diabetes With Dapagliflozin (READ Trial) | | |
New diabetes clinical trial: A Study Comparing the Injection Site Pain Experience After the Injection of 2 Different Solutions of Semaglutide With 2 Different Injection Pens, a Compound for the Treatment of Type 2 Diabetes and Obesity | | |
New diabetes clinical trial: An Audit of the Impact of Tailored Information Delivered Via a Digital Learning Platform | | |
New diabetes clinical trial: Hepcidin and Glucose Metabolism | | |
New diabetes clinical trial: Effect of Continuous vs Intermittent Aerobic Exercise on Glycemic Control in a Barbadian Population With Type 2 Diabetes | | |
New diabetes clinical trial: Cardiac Rest and Stress Metabolism in Patients With Type 2 Diabetes | | |
New diabetes clinical trial: Observational Study: Glycemic Control & CV Outcomes Among Patients With T2DM Newly Initiating GLP1-RAs vs Basal Insulin | | |
New diabetes clinical trial: Phenotypic and Genotypic Characterization of New-onset Type I Diabetes | | |
New diabetes clinical trial: Statin Compliance of Patients With Non-insulin-dependent Diabetes | | |
Няма коментари:
Публикуване на коментар